Article(id=1330225296101454655, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2022.03.019, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1638720000000, receivedDateStr=2021-12-06, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795080024980, onlineDateStr=2026-11-19, pubDate=1646841600000, pubDateStr=2022-03-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795080024980, onlineIssueDateStr=2026-11-19, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795080024980, creator=13701087609, updateTime=1795080024980, updator=13701087609, issue=Issue{id=1330225126483800273, tenantId=1146029695717560320, journalId=1319690329412173987, year='2022', volume='43', issue='3', pageStart='211', pageEnd='341', issueExtLink='null', onlineDate='null', pubDate='1646841600000', pubDateStr='2022-03-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795079984541, creator='13701087609', updateTime=1795084691298, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330244868573606556, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330244868573606557, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1330225126483800273, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=319, endPage=324, ext={EN=ArticleExt(id=1330225296315364160, articleId=1330225296101454655, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=International experience of risk sharing arrangements for chimeric antigen receptor T-cell therapy, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=
Chimeric antigen receptor T-cell (CAR-T) therapy, as an innovative therapy, has high clinical value, but its high treatment cost and uncertainty of long-term efficacy bring challenges to medical insurance access. This paper explored the design framework and key elements of CAR-T therapy risk sharing protocol by combing international experience and Chinese practice characteristics, in order to provide reference for Chinese health insurance access policy.
, authors=Jie TIAN
1, Xingrong LI
2, Jun LIU
2, Jing WU
1, *, authorsList=Jie TIAN, Xingrong LI, Jun LIU, Jing WU, authorCompany=null, correspAuthors=Jing WU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1330225296571216705, articleId=1330225296101454655, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=嵌合抗原受体T细胞疗法风险分担协议的国际经验借鉴, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=
嵌合抗原受体T细胞(chimeric antigen receptor T-cell,CAR-T)疗法作为一种创新疗法,具有较高的临床价值,但其高昂的治疗费用、长期疗效的不确定性给医保准入带来了挑战。该文通过梳理国际经验,探索CAR-T细胞疗法的风险分担协议的设计框架和关键要素,结合国际经验和我国实践特征进行设计规划,以期为我国医保支付政策提供参考。
, authors=田洁
1, 李幸蓉
2, 刘君
2, 吴晶
1, *, authorsList=田洁, 李幸蓉, 刘君, 吴晶, authorCompany=null, correspAuthors=吴晶, authorNote=
, correspAuthorsNote=
吴晶,教授,博士生导师,研究方向:卫生经济学与卫生政策评估。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=jGJt2BPpcFd4bM5I1LNjKA==, magXml=AzVRzbgmcSMTps5aA5Y4pQ==, pdfUrl=null, pdf=RyK7O0ZyEFJlXvQYMVy5mw==, pdfFileSize=1757943, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=m0w4IZxA1PmBNtCiIQ24TA==, mapNumber=null, fund=null)}, authors=[Author(id=1330225296948704073, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225297040978763, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, authorId=1330225296948704073, language=EN, stringName=Jie TIAN, firstName=Jie, middleName=null, lastName=TIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225297112281932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, authorId=1330225296948704073, language=CN, stringName=田洁, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, address=
1.天津大学药物科学与技术学院,天津 300072, bio={"content":"
田洁,硕士研究生,研究方向:药物经济学。
"}, bioImg=null, bioContent=
田洁,硕士研究生,研究方向:药物经济学。
, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225296772543298, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, xref=1., ext=[AuthorCompanyExt(id=1330225296780931907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296772543298, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225296789320516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296772543298, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.天津大学药物科学与技术学院,天津 300072)])]), Author(id=1330225297166807886, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225297242305360, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, authorId=1330225297166807886, language=EN, stringName=Xingrong LI, firstName=Xingrong, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.Real-World Solutions, IQVIA, Shanghai 200041, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225297338774353, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, authorId=1330225297166807886, language=CN, stringName=李幸蓉, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.艾昆纬卫生经济与真实世界研究,上海 200041, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225296860623685, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, xref=2., ext=[AuthorCompanyExt(id=1330225296864817990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296860623685, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Real-World Solutions, IQVIA, Shanghai 200041, China), AuthorCompanyExt(id=1330225296873206599, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296860623685, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.艾昆纬卫生经济与真实世界研究,上海 200041)])]), Author(id=1330225297410077523, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1330225297489769301, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, authorId=1330225297410077523, language=EN, stringName=Jun LIU, firstName=Jun, middleName=null, lastName=LIU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.Real-World Solutions, IQVIA, Shanghai 200041, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225297556878166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, authorId=1330225297410077523, language=CN, stringName=刘君, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
2, address=
2.艾昆纬卫生经济与真实世界研究,上海 200041, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225296860623685, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, xref=2., ext=[AuthorCompanyExt(id=1330225296864817990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296860623685, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Real-World Solutions, IQVIA, Shanghai 200041, China), AuthorCompanyExt(id=1330225296873206599, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296860623685, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.艾昆纬卫生经济与真实世界研究,上海 200041)])]), Author(id=1330225297619792728, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1330225297699484506, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, authorId=1330225297619792728, language=EN, stringName=Jing WU, firstName=Jing, middleName=null, lastName=WU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1330225297787564891, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, authorId=1330225297619792728, language=CN, stringName=吴晶, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=
1, *, address=
1.天津大学药物科学与技术学院,天津 300072, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1330225296772543298, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, xref=1., ext=[AuthorCompanyExt(id=1330225296780931907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296772543298, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225296789320516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296772543298, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.天津大学药物科学与技术学院,天津 300072)])])], keywords=[Keyword(id=1330225297892422493, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, language=EN, orderNo=1, keyword=chimeric antigen receptor T-cell therapy), Keyword(id=1330225297967919966, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, language=EN, orderNo=2, keyword=oncology), Keyword(id=1330225298030834527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, language=EN, orderNo=3, keyword=risk sharing), Keyword(id=1330225298114720608, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, language=EN, orderNo=4, keyword=medical insurance access), Keyword(id=1330225298169246561, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, language=CN, orderNo=1, keyword=嵌合抗原受体T细胞疗法), Keyword(id=1330225298253132642, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, language=CN, orderNo=2, keyword=肿瘤), Keyword(id=1330225299930854243, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, language=CN, orderNo=3, keyword=风险分担), Keyword(id=1330225300010546020, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, language=CN, orderNo=4, keyword=医保准入)], refs=[Reference(id=1330225300157346661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=US FDA. Approved cellular and gene therapy products[EB/OL]. [2022-03-01]. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products., articleTitle=null, refAbstract=null), Reference(id=1330225300274787174, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=European Medicines Agency (EMA). Public data from Article 57 database[EB/OL]. [2022-02-21]. https://www.ema.europa.eu/en/human-regulatory/post-authorisation/data-medicines-iso-idmp-standards/public-data-article-57-database., articleTitle=null, refAbstract=null), Reference(id=1330225300341896039, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局. 国家药监局批准阿基仑赛注射液上市[EB/OL]. [2021-06-23]. https://www.nmpa.gov.cn/yaowen/ypjgyw/20210623094232187.html., articleTitle=null, refAbstract=null), Reference(id=1330225300425782120, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=国家药品监督管理局. 2021年09月03日药品批准证明文件待领取信息发布[EB/OL]. [2021-09-03]. https://www.nmpa.gov.cn/zwfw/sdxx/sdxxyp/yppjfb/20210903084004127.html., articleTitle=null, refAbstract=null), Reference(id=1330225300543222635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Corbett MS, Webster A, Hawkins R,
et al. Innovative regenerative medicines in the EU: a better future in evidence?[J]. BMC Med, 2017, 15(1): 49., articleTitle=null, refAbstract=null), Reference(id=1330225300631303020, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Carlson JJ, Chen S, Garrison LP Jr. Performance-based risk-sharing arrangements: an updated international review[J]. Pharmacoeconomics, 2017, 35(10): 1063-1072., articleTitle=null, refAbstract=null), Reference(id=1330225300736160621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Jørgensen J, Kefalas P. The use of innovative payment mechanisms for gene therapies in Europe and the USA[J]. Regen Med, 2021, 16(4): 405-422., articleTitle=null, refAbstract=null), Reference(id=1330225300811658094, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=任磊, 柴逸峰, 张黎. 法国药品临时使用授权制度对我国同情用药制度的启示[J]. 中国新药与临床杂志, 2020, 39(8): 463-467., articleTitle=null, refAbstract=null), Reference(id=1330225300933292911, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=NHS England. Appraisal and funding of cancer drugs from July 2016 (including the new Cancer Drugs Fund). A new deal for patients, taxpayers and industry[EB/OL]. [2016-07-08]. https://www.england.nhs.uk/wp-content/uploads/2013/04/cdf-sop.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225301004596080, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Garattini L, Casadei G. Risk sharing agreements: what lessons from Italy?[J]. Int J Technol Assess Health Care, 2011, 27(2): 169-172., articleTitle=null, refAbstract=null), Reference(id=1330225301067510641, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=National institute for Health and Care Excellence (NICE). Cancer Drugs Fund-Managed Access Agreement-tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years [TA554][EB/OL]. [2018-12-21]. http://www.nice.org.uk/guidance/ta554/resources/managed-access-agreement-december-2018-pdf-6651288397., articleTitle=null, refAbstract=null), Reference(id=1330225301155591026, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=National institute for Health and Care Excellence (NICE). Cancer Drugs Fund-Managed Access Agreement. Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies[EB/OL]. [2019-03-13]. http://www.nice.org.uk/guidance/ta567/documents/committee-papers-4., articleTitle=null, refAbstract=null), Reference(id=1330225301222699891, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=National institute for Health and Care Excellence (NICE). Cancer Drugs Fund-Managed Access Agreement. Axicabtagene ciloleucel for treating diffuse large B cell lymphoma and primary mediastinal B cell lymphoma after 2 or more systemic therapies[TA559][EB/OL]. [2019-01-23]. http://www.nice.org.uk/guidance/ta559/resources/managed-access-agreement-january-2019-pdf-6660053245., articleTitle=null, refAbstract=null), Reference(id=1330225301289808756, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Agenzia Italiana del Farmaco (AIFA). Regime di rimborsabilita'e prezzo del medicinale per uso umano 《Kymriah》. (Determina n. 1264/2019). (19A05147) (GU Serie Generale n. 188 del 12-08-2019)[EB/OL]. [2019-08-07]. https://www.gazzettaufficiale.it/eli/id/2019/08/12/19A05147/SG., articleTitle=null, refAbstract=null), Reference(id=1330225301348529013, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Agenzia Italiana del Farmaco (AIFA). Regime di rimborsabilita'e prezzo del medicinale per uso umano 《Yescarta》. (Determina n. DG/1643/2019). (19A06932) (GU n. 264 del 11-11-2019)[EB/OL]. [2019-11-04]. http://www.aifa.gov.it/documents/20142/961234/DeterminaDG-1643-2019Yescarta.pdf/26464c52-5e7b-e97d-74d5-f66f69039fa0., articleTitle=null, refAbstract=null), Reference(id=1330225301407249270, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Ministerio de Sanidad Consumo y Bienestar Social (MSCBS). Protocolo farmacoclínico del uso de tisagenlecleucel y axicabtagen ciloleucel en linfoma b difuso de células grandes en el sistema nacional de salud[EB/OL]. [2019-11-08]. https://www.mscbs.gob.es/profesionales/farmacia/pdf/20191128_Protocolo_farmacoclinico_tisagenlecleucel_axicel_LBDCG.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225301470163831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Gemeinsamer Bundesausschuss (G-BA). Tragende gründe-zum beschluss des gemeinsamen bundesausschusses über eine anderung der arzneimittel-richtlinie (AM-RL): anlage Ⅻ- nutzenbewertung von arzneimitteln mit neuen wirkstoffen nach § 35a sgbⅤ- tisagenlecleucel neubewertung nach fristablauf: akute lymphatische B-Zell-Leukämie[EB/OL]. [2020-09-17]. http://www.g-ba.de/downloads/40-268-6854/2020-09-17AM-RL-ⅫTisagenlecleucelALLD-529TrG.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225301541467000, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Gemeinsamer Bundesausschuss (G-BA). Tragende gründe-zum beschluss des gemeinsamen bundesausschusses über eine anderung der arzneimittel-richtlinie (AM-RL): anlage Ⅻ- beschlüsse über die nutzenbewertung von arzneimitteln mit neuen wirkstoffen nach § 35a sgbⅤ-axicabtagen-ciloleucel[EB/OL]. [2019-05-02]. http://www.g-ba.de/downloads/40-268-5742/2019-05-02AM-RL-ⅫAxicabtagen-CiloleucelD-406D-416TrG.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225301646324601, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Novartis. Novartis Pharma GmbH und GWQ Service Plus schließen vertrag über ein innovatives Erstattungsmodell für die CAR-T-Zelltherapie[EB/OL]. [2019-03-06]. http://www.dgap.de/dgap/News/corporate/novartis-pharma-gmbh-und-gwq-serviceplus-schliessen-vertrag-ueber-ein-innovatives-erstattungsmodell-fuer-die-cartzelltherapie/?newsID=1132071., articleTitle=null, refAbstract=null), Reference(id=1330225301713433466, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Maudit H. Major German payers sign pay for performance agreements on CAR-Ts[EB/OL]. [2019-06-21]. http://www.apmhealtheurope.com/freestory/0/64434/major-german-payers-sign-pay-for-performance-agreements-on-car-ts., articleTitle=null, refAbstract=null), Reference(id=1330225301797319549, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Novartis. Novartis receives first ever FDA approval for a CAR-T cell therapy, Kymriah (TM) (CTL019), for children and young adults with B-cell ALL that is refractory or has relapsed at least twice[EB/OL]. [2017-08-30]. https://www.novartis.com/news/media-releases/novartis-receives-first-ever-fda-approval-car-t-cell-therapy-kymriahtm-ctl019-children-and-young-adults-b-cell-all-refractory-or-has-relapsed-least-twice., articleTitle=null, refAbstract=null), Reference(id=1330225301856039806, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Centers for Medicare & Medicaid Services (CMS). Proposed decision memo for chimeric antigen receptor (CAR) T-cell therapy for cancers (CAG-00451N)[EB/OL]. [2019-02-15]. http://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=291., articleTitle=null, refAbstract=null), Reference(id=1330225301914760063, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=Haute Autorité de Santé(HAS). Commission de la transparence-avis 12 dé cembre 2018 - tisagenlecleucel[EB/OL]. [2018-12-12]. http://www.has-sante.fr/upload/docs/application/pdf/2018-12/kymriah_ldgcb_pic_ins_avis3_ct17238.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225301973480320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Agence Technique De L'information Sur L'hospitalisation. Campagne tarifaire 2019 - Nouveaux Recueils - Traitements de type CAR-T cells[EB/OL]. [2019-07-22]. https://www.atih.sante.fr/sites/default/files/public/content/3595/notice_technique_atih-371-6-2019_car-t-cells.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225302048977793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Ministerio de Sanidad Consumo y Bienestar Social (MSCBS). Preguntas y respuestas frecuentes sobre el sistema de información para determinar el valor terapéutico en la práctica clínica real de los medicamentos de alto impacto sanitario y económico en el sistema nacional de salud (Valtermed)[EB/OL]. [2019-10-21]. https://www.sanidacl.gob.es/profesionales/farmacia/valtermed/docs/VALTERMED_Preguntas_y_Respuestas.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225302103503746, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Center for International Blood & Marrow Transplant Research (CIBMTR). CIBMTR to track long-term outcomes data for Kymriah
®[EB/OL]. [2021-11-30]. https://www.cibmtr.org/ReferenceCenter/NewsReleases/Documents/CIBMTR%20Novartis%20Press%20Release%20FINAL.pdf., articleTitle=null, refAbstract=null), Reference(id=1330225302162224003, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=Center for International Blood & Marrow Transplant Research (CIBMTR). CIBMTR announces collaboration with Kite to track long-term outcomes data for Yescarta
®[EB/OL]. [2021-11-30]. https://www.cibmtr.org/ReferenceCenter/NewsReleases/Documents/CIBMTR%20Kite%20Press%20Release%20FINAL.pdf., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1330225296772543298, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, xref=1., ext=[AuthorCompanyExt(id=1330225296780931907, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296772543298, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.School of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China), AuthorCompanyExt(id=1330225296789320516, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296772543298, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
1.天津大学药物科学与技术学院,天津 300072)]), AuthorCompany(id=1330225296860623685, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, xref=2., ext=[AuthorCompanyExt(id=1330225296864817990, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296860623685, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.Real-World Solutions, IQVIA, Shanghai 200041, China), AuthorCompanyExt(id=1330225296873206599, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1330225296101454655, companyId=1330225296860623685, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=
2.艾昆纬卫生经济与真实世界研究,上海 200041)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li {
margin-right: 18px;
}
@media (max-width: 1442px) {
.style-1 .main-menu ul>li a {
font-size: 16px;
padding: 10px 0;
}
}, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2022.03.019, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.03.019, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2022.03.019, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2022.03.019, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1646841600000, fullTextJson=null, articleText=null, reference=null)